Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.135
-0.035-0.68%
Volume:141.52K
Turnover:731.80K
Market Cap:4.19B
PE:-22.01
High:5.275
Open:5.170
Low:5.130
Close:5.170
52wk High:10.940
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.52
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-3.45%
ROA:-1.93%
PB:0.99
PE(LYR):-22.01
PS:3.84

Loading ...

Ocumension Therapeutics Files List of Board, Board Committee Members with Disclosure Responsibilities

Reuters
·
Jun 30

Ocumension Therapeutics Appoints Beibei Zhuang as Independent Director, Audit Committee Chair

Reuters
·
Jun 30

Huiyu Pharmaceutical Subsidiary Receives Clinical Trial Approval for HY-1016 Sustained-Release Injection

Stock News
·
Jun 30

ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases

Stock News
·
Jun 29

Metis TechBio-P Shares Surge Over 10% as AI Drug Discovery Sector Enters Validation Phase

Stock News
·
Jun 29

Huiyu Pharmaceutical Subsidiary Secures International Market Approvals for Multiple Products

Stock News
·
Jun 25

ASCLETIS PHARMA CONDUCTS HK$2.02 MILLION SHARE BUYBACK

Stock News
·
Jun 24

ASCLETIS-B Receives FDA Clearance for Phase I Study of Its Monthly Subcutaneous GLP-1R/GIPR Dual Agonist Peptide ASC35 in Obesity

Stock News
·
Jun 23

ASCLETIS-B Executes Share Buyback on June 22, Spending HK$1.901 Million

Stock News
·
Jun 22

Jianyou Shares' Board Secretary Huang Xiwei: Global Strategy Anchored, Three-Phase Plan Strengthens Full Pharmaceutical Industry Chain

Deep News
·
Jun 22

Hong Kong IPO Prospectus for Zelgen Biopharmaceutical Lapses

Stock News
·
Jun 22

Targeting the Brain's 'Wake Switch': Alkermes's Narcolepsy Drug Shows Promising Mid-Stage Data, Igniting Race in Orexin Pathway

Stock News
·
Jun 18

HighLight Pharma's Second Hong Kong Listing Bid: Zero Revenue, Pipeline Gaps, and Core Product's Commercial Viability Questioned Under $1.2 Billion Bet Pressure

Deep News
·
Jun 18

ASCLETIS-B Executes Share Buyback Totaling HK$1.97 Million

Stock News
·
Jun 17

Legal Claims Initiated Against Shenwu Energy Saving, Hainan Poly Pharm. Case Resubmitted to Court

Deep News
·
Jun 17

Legal Action Against Puli Pharmaceutical Continues to Gather Momentum, Initial Court Victory Secured

Deep News
·
Jun 17

ASCLETIS-B Executes Share Buyback, Spending HK$1.86 Million

Stock News
·
Jun 16

ASCLETIS-B Executes Share Buyback, Spending HK$1,918,300 on June 15

Stock News
·
Jun 15

ASCLETIS-B Executes HK$1.97 Million Share Buyback on June 11

Stock News
·
Jun 11

ASCLETIS-B Executes Share Buyback, Spending Nearly HK$2 Million

Stock News
·
Jun 10